These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3242981)

  • 1. Correlation of two different assays for urinary kallikrein in normotensive and hypertensive subjects.
    Maier M; Jerabek I; Reissert G; Höltzl E; Binder BR
    Clin Chim Acta; 1988 Dec; 178(2):127-39. PubMed ID: 3242981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced ratio of active-to-total urinary kallikrein in essential hypertension.
    Lieberthal W; Arbeit L; Oza NB; Bernard DB; Levinsky NG
    Hypertension; 1983; 5(4):603-9. PubMed ID: 6345366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The excretion of human urinary kallikrein quantity and activity in normal and low renin subgroups of essential hypertension.
    Ura N; Shimamoto K; Nakao T; Ogasawara A; Tanaka S; Mita T; Nishimiya T; Iimura O
    Clin Exp Hypertens A; 1983; 5(3):329-37. PubMed ID: 6188559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Existence of prokallikrein in the kidney. Its biochemical properties compared to three active glandular kallikreins from the kidney, serum, and urine of the rat.
    Nishimura K; Shimizu H; Kokubu T
    Hypertension; 1983; 5(2):205-10. PubMed ID: 6550028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excretion of human urinary kallikrein quantity measured by a direct radioimmunoassay of human urinary kallikrein in patients with essential hypertension and secondary hypertensive diseases.
    Shimamoto K; Ura N; Tanaka S; Ogasawara A; Nakao T; Nakahashi Y; Chao J; Margolius HS; Iimura O
    Jpn Circ J; 1981 Sep; 45(9):1092-7. PubMed ID: 6913609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of activatable kallikrein in one-kidney pole-ligated hypertensive rats.
    Vergara M; Corthorn J
    J Hypertens; 1983 Dec; 1(4):387-91. PubMed ID: 6085335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():247s-250s. PubMed ID: 396074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological analysis of rat pancreatic prokallikrein activation.
    Woodley CM; Chao J; Chao L
    Biochim Biophys Acta; 1985 Jul; 829(3):408-14. PubMed ID: 3890956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivities of human urinary prokallikrein and kallikrein toward rabbit antibodies with special reference to enzyme immunoassay.
    Irie A; Takahashi S; Katayama Y; Shibata Y; Miyake Y
    Clin Chim Acta; 1988 Apr; 173(3):289-97. PubMed ID: 3133137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of suppression of renal kallikrein activity in low renin essential hypertension and renoparenchymal hypertension.
    Shimamoto K; Masuda A; Ando T; Ura N; Nakagawa M; Mori Y; Nakagawa H; Sakakibara T; Ogata H; Iimura O
    Hypertension; 1989 Oct; 14(4):375-8. PubMed ID: 2676859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on kallikrein activity in diabetic patient with hypertension caused by nephropathy].
    Kunii N
    Nihon Jinzo Gakkai Shi; 1989 Jan; 31(1):39-48. PubMed ID: 2746999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved method for the measurement of rat tissue kallikrein using a monoclonal antibody which recognizes only active enzyme.
    Ando T; Chao J; Chao L; Margolius HS
    Adv Exp Med Biol; 1986; 198 Pt B():515-22. PubMed ID: 3643738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlations between circulation levels of natriuretic atrial peptide and urinary excretion of kallikrein in young normotensive and hypertensive subjects].
    Ferri C; Cammarella I; Giarrizzo C; Bellini C; Astorre P; Di Zenzo P; Santucci A; Musca A; Balsano F
    Ann Ital Med Int; 1991; 6(2):217-23. PubMed ID: 1836137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of renal rK1-kallikrein in spontaneously hypertensive rats.
    Goud HD; Oza NB; Mitsialis SA; Levinsky NG
    Ren Physiol Biochem; 1993; 16(3):125-30. PubMed ID: 7686678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in urinary tissue kallikrein excretion in black African women with hypertensive disorders of pregnancy.
    Khedun SM; Naicker T; Moodley J; Naidoo S; Bhoola KD
    Immunopharmacology; 1997 Jun; 36(2-3):243-7. PubMed ID: 9228553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of human urinary prokallikrein. Identification of the site of activation by the metalloproteinase thermolysin.
    Takada Y; Skidgel RA; Erdös EG
    Biochem J; 1985 Dec; 232(3):851-8. PubMed ID: 3937523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating kallikreins in normotensive and hypertensive humans: effects of mineralocorticoid administration.
    Ohman KP
    Blood Press; 1997 Jul; 6(4):214-22. PubMed ID: 9296308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired renal kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.
    Stumpe KO; Overlack A; Ressel C; Krück F
    Agents Actions; 1980 Sep; 10(4):349-52. PubMed ID: 6905641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral potassium on urinary kallikrein excretion in essential hypertension.
    Murakami E; Hiwada K; Kokubu T; Imamura Y
    Adv Exp Med Biol; 1989; 247B():133-7. PubMed ID: 2610052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.